Document is current
Any future updates will be listed below
-
Authors
Liu, Jiaxuan
He, Maiyue
Jiang, Mingxia
Zhou, Shihan
Zhang, Mengqi
Li, Yiqun
Chen, Shanshan
Cai, Ruigang
Mo, Hongnan
Lan, Bo
Ma, Fei
Xu, Binghe
Li, Qiao
-
Funding
Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences (2021-I2M-1-014, 2022-I2M-C&T-B-072)
- License Information
-
More Information
Article History
Received: 25 March 2024
Accepted: 7 October 2024
First Online: 18 October 2024
Declarations
:
: The present study was approved by the ethics committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval No. NCC1953) and was registered at clinicaltrials.gov (NCT03923179) in April 18, 2019. The study design and conduct complied with all relevant guidelines and regulations regarding the use of human study participants and was conducted in accordance with the criteria set by the Declaration of Helsinki. All patients voluntarily participated and provided written informed consent before the initiation of any study-related treatment or procedures.
: The authors declare no competing interests.
